Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2724-2734

  Fehlings, Michael ^a,b   Drobbe, Lea ^b   Moos, Verena ^a   Viveros, Pablo Renner ^a   Hagen, Jana ^a,b   Beigier Bompadre, Macarena ^b   Pang, Ervinna ^b   Belogolova, Elena ^b   Churin, Yuri ^b   Schneider, Thomas ^a   Meyer, Thomas F ^b   Aebischer, Toni ^b,c   Ignatius, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD206 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH BIOPSY; UPREGULATION;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MACROPHAGES; MONOCYTES; PHAGOCYTOSIS;

EID: 84864799201     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00381-12     Document Type: Article

References (87)

1. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1β and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949.
2. Ahuja V, Eisenblätter M, Ignatius R, Stahlmann R. 2009. Ammonium perfluorooctanoate substantially alters phenotype and cytokine secretion of human monocyte-derived dendritic cells in vitro. Immunopharmacol. Immunotoxicol. 31:641- 646.
3. Amedei A, et al. 2006. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116:1092-1101.
4. Appelmelk BJ, Monteiro MA, Martin SL, Moran AP, Vandenbroucke-Grauls CMJ. 2000. Why Helicobacter pylori has Lewis antigens. Trends Microbiol. 8:565-570.
5. Appelmelk BJ, et al. 2003. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170:1635-1639.
6. Asahi A, et al. 2008. Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 118:2939 -2949.
7. Bamford KB, et al. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482- 492.
8. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
9. Bauer B, Meyer TF. 2011. The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers 2011:1-23.
10. Baugh JA, Bucala R. 2002. Macrophage migration inhibitory factor. Crit. Care Med. 30(Suppl 1):S27-S35.
11. Benoit M, Desnues B, Mege JL. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181:3733-3739.
12. Bergin PJ, et al. 2004. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter 9:201-210.
13. Bergman MP, et al. 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200:979 -990.
14. Bimczok D, et al. 2010. Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal Immunol. 3:260 -269.
15. Bond E, et al. 2009. Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity. J. Immunol. Methods 348:42-56.
16. Borlace GN, Butler RN, Brooks DA. 2008. Monocyte and macrophage killing of Helicobacter pylori: relationship to bacterial virulence factors. Helicobacter 13:380 -387.
17. Caruso R, et al. 2008. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 38:470-478.
18. Caruso R, et al. 2007. IL-21 is highly produced in Helicobacter pyloriinfected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178:5957-5965.
19. Chabaud M, et al. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42:963-970.
20. Chavez-Sanchez L, et al. 2010. The activation of CD14, TLR4, and TLR2 bymmLDLinduces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis. 9:117.
21. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. 1991. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32:1473-1477.
22. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. 2007. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol. Med. Microbiol. 50:157- 164.
23. D'Elios MM, et al. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967.
24. Engering A, et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118 -2126.
25. Galgani M, et al. 2004. Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect. Immun. 72:4480-4485.
26. Ghoreschi K, et al. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467:967-971.
27. Goerdt S, Orfanos CE. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10:137-142.
28. Gordon S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
29. Gordon S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37(Suppl 1):S9 -S17.
30. Gordon S, Martinez FO. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32:593- 604.
31. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964.
32. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TBH. 2009. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10:1081-1088.
33. Grubman A, et al. 2010. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell. Microbiol. 12:626-639.
34. Guiney DG, Hasegawa P, Cole SP. 2003. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 71:4163- 4166.
35. Hafsi N, et al. 2004. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J. Immunol. 173: 1249-1257.
36. Hansson M, et al. 2006. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3β) after exposure to Helicobacter pylori. Microbes Infect. 8:841- 850.
37. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ, Smith PD. 1996. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 111: 419-425.
38. Harris PR, et al. 2008. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134:491- 499.
39. Hornung V, et al. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:4531- 4537.
40. Huang XR, et al. 2001. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 121:619-630.
41. Jasny E, et al. 2008. IL-12-impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation. J. Immunol. 180:6629-6639.
42. Jonuleit H, et al. 1997. Pro-inflammatory cytokines and prostaglandins. Eur. J. Immunol. 27:3135-3142.
43. Kao JY, et al. 2010. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046 -1054.
44. Kerrigan AM, Brown GD. 2009. C-type lectins and phagocytosis. Immunobiology 214:562-575.
45. + T lymphocytes. Infect. Immun. 78:845- 853.
46. Köhalmi F, Strausz J, Egerváry M, Szekeres G, Tímár J. 1997. Expression of macrophage markers in childhood and adult Langerhans histiocytosis (LCH). Orv. Hetil. 138:1399 -1402. (In Hungarian.)
47. Kranzer K, et al. 2004. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 72:4416- 4423.
48. Kranzer K, et al. 2005. Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect. Immun. 73:4180.
49. Kurasawa K, et al. 2000. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43:2455-2463.
50. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 66:5964 -5971.
51. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71:1755-1762.
52. Mai UE, et al. 1991. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 87:894 -900.
53. Mantovani A, Sica A, Locati M. 2007. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37:14 -16.
54. Maris NA, et al. 2006. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur. Respir. J. 28:622- 626.
55. Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front. Biosci. 13:453- 461.
56. Martinez-Pomares L, Linehan SA, Taylor PR, Gordon S. 2001. Binding properties of the mannose receptor. Immunobiology 204:527-535.
57. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164:6166-6173.
58. Mitchell P, et al. 2007. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75:810-819.
59. Monteiro MA, et al. 1998. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. J. Biol. Chem. 273:11533-11543.
60. Moos V, et al. 2010. Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 138:210 -220.
61. Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD. 2007. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J. Leukoc. Biol. 82:1542-1553.
62. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958 -969.
63. Necchi V, Manca R, Ricci V, Solcia E. 2009. Evidence for transepithelial dendritic cells in human H. pylori active gastritis. Helicobacter 14:208- 222.
64. Odenbreit S, et al. 2006. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 11:196- 207.
65. Popa C, et al. 2006. MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis. Cytokine 36:51-56.
66. Quah BJC, Parish CR. 2010. The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. J. Vis. Exp. 44:2259. doi:10.3791/2259.
67. + T cell responses in Helicobacter pylori-infected individuals. Clin. Exp. Immunol. 123:81- 87.
68. Quiding-Järbrink M, Raghavan S, Sundquist M. 2010. Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One 5:e15018. doi:10.1371/ journal.pone.0015018.
69. Randolph GJ, Jakubzick C, Qu C. 2008. Antigen presentation by monocytes and monocyte-derived cells. Curr. Opin. Immunol. 20:52- 60.
70. Ravetch JV, Bolland S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-290.
71. Rescigno M, et al. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367.
72. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109 -1118.
73. + T cells in vitro. Immunology 92:478-486.
74. Schreibelt G, et al. 2010. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anticancer immunotherapy. Cancer Immunol. Immunother. 59:1573-1582.
75. Soilleux EJ, et al. 2002. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71:445- 457.
76. + lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect. Immun. 66:5543-5546.
77. Steinman RM, Hemmi H. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58.
78. Trinchieri G. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83-243.
79. van Die I, et al. 2003. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 13:471- 478.
80. Verreck FA, et al. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U. S. A. 101:4560-4565.
81. Viala J, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166 -1174.
82. Wilson KT, Crabtree JE. 2007. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133:288 -308.
83. Wilson NJ, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950- 957.
84. Wong BL, et al. 2009. Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am. J. Pathol. 174:1319- 1328.
85. Wunder C, et al. 2006. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 12:1030 -1038.
86. Xia HH-X, et al. 2004. Helicobacter pylori infection is associated with increased expression of macrophage migratory inhibitory factor- by epithelial cells, T cells, and macrophages-in gastric mucosa. J. Infect. Dis. 190:293-302.
87. Zarrilli R, Ricci V, Romano M. 1999. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell. Microbiol. 1:93-99.